Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity

BMC Research Notes

Table 2 Clinical and metabolic parameters of subjects (N = 105)

Feature		Frequency	Percent
Somatic illness	No	78	74.3
	Cardiovascular illness	4	3.8
	Other illnesses	14	13.3
Smoking	Yes	67	63.8
	No	31	29.5
Medications	No	87	82.9
	With known effects on investigated features (Contraceptives)	9	8.6
	Other medications	4	3.8
Elevated hepatic enzymes	No	77	73.3
	Yes	19	18.1
Diet	Continental	75	71.4
	Mediterranean	13	12.4
	Mixed	10	9.5
Positive family history	No	25	23.8
	Diabetes	12	11.4
	Cardiovascular disease	32	30.5
	Obesity	2	1.9
	More than one	34	32.4
Hypertension (>135/85 mmHg)	No	79	75.2
	Yes	19	18.1
BMI (kg/m²)	<25	77	73.3
	25.01-30	23	21.9
	> 30.01	5	4.8
Abdominal obesity (WHR >90 (M), >85 (F)	No	85	83.3
	Yes	17	16.7
Hypertriglyceridemia (>1.7 mmol/L)	No	93	88.6
	Yes	12	11.4
Hypercholesterolemia (>5 mmol/L)	No	81	77.1
	Yes	24	22.9
HDL-C (<1.0 mmol/L)	No	98	93.3
	Yes	7	6.7
LDL-C (>3 mmol/L)	No	81	77.1
	Yes	24	22.9
Glucose levels (>6.4 mmol/L)	Hypoglycemia	4	3.8
	Normal	100	95.2
	Hyperglycemia	1	1.0
CRP levels (mg/L)	< 1	61	58.1
	1-3	34	32.4
	> 3	10	9.5
Elevated urate levels (>383 mmol/L)	No	93	88.6
	Yes	12	11.4

M - male; F - female; HDL-C - high density lipoprotein; LDL-C - low density lipoprotein cholesterol; CRP - C-reactive protein

ISSN: 1756-0500